• Franchise Manager Immunology and Biologic Launch Lead

  

  Franchise Manager Immunology and Biologic Launch Lead

  Citi - Ziemeļreina-Vestfālene | 2024-04-18

  With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We…

  • Citas

  Citi - Ziemeļreina-Vestfālene

• Franchise Manager Immunology and Biologic Launch Lead

  

  Franchise Manager Immunology and Biologic Launch Lead

  Citi - Ziemeļreina-Vestfālene | 2024-04-18

  With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We…

  • Citas

  Citi - Ziemeļreina-Vestfālene

• Franchise Manager Immunology and Biologic Launch Lead

  

  Franchise Manager Immunology and Biologic Launch Lead

  Citi - Ziemeļreina-Vestfālene | 2024-04-18

  With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We…

  • Citas

  Citi - Ziemeļreina-Vestfālene

• PhD Biology - Immunohistology, Fluorescence (m/f/d)

  

  PhD Biology - Immunohistology, Fluorescence (m/f/d)

  Citi - Baden-Vurttemberga | 2024-04-18

  Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance This research project starts in October 2024…

  • Pilna laika

  Citi - Baden-Vurttemberga

• Medical Student (f/m/x)

  

  Medical Student (f/m/x)

  Citi - Baden-Vurttemberga | 2024-04-18

  Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance This research project starts in October 2024…

  • Pilna laika

  Citi - Baden-Vurttemberga

• Biologist (f/m/x)

  

  Biologist (f/m/x)

  Citi - Baden-Vurttemberga | 2024-04-18

  Research Project for an MD student to determine the role of non-canonical G proteins in melanoma progression and therapy resistance This research project starts in October 2024…

  • Pilna laika

  Citi - Baden-Vurttemberga

• Physician - Medical Safety, Oncology (m/f/d)

  

  Physician - Medical Safety, Oncology (m/f/d)

  Citi - Bavārija | 2024-04-18

  About ITM ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and…

  • Citas

  Citi - Bavārija

Vēlaties redzēt vairāk? Spidiet šeit Veselības aprūpe - Vācija